Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TRANSITION THERAPEUTICS INC. T.TTH

"Transition Therapeutics Inc is a product-focused biopharmaceutical company. The Company is engaged in developing therapeutics for disease indications with markets. Its technologies are focused on the treatment of Alzheimer's disease and diabetes."


TSX:TTH - Post by User

Comment by deninsaskon Sep 25, 2007 8:29pm
182 Views
Post# 13467902

"Dr. Cruz Quips..........From N Y C ! ! #6"

"Dr. Cruz Quips..........From N Y C ! ! #6" .....Transition guards it's Drug Discoverys and doesn't show any data or anything from these early stage Drugs. Recall Dr. Cruz mentioning that 2 compounds for Cardiovascular Disease will be given the go ahead to move forward into Pre-Clinicals. At this conference he didn't mention any targets and just vaguely discussed that 4 or 5 Lead Molecules had been discovered. He did however Extoll it's Utilitarian Virtues....... Dr. Cruz......."Transition has a Drug Discovery Engine, but all I can tell you is that this proprietary Lead Molecule Discovery Technology we can develop Lead Molecules to Validated Targets in novel targets. We have about 4 or 5 that are currently in progress and we already have AT LEAST 2 Lead Molecules that could be entering Pre-Clinical development by the end of the year."...."We also use this technology to Expand our Intellectual Property for our Existing Therapys, so it's an ongoing process and it provides us with a lot of flexibility in where we want to go in the future." Heck of a good investment Dr. Cruz made there getting that!! What a Steal man!! Paying for itself already with AZD-103 being run through it and resulting us$200 Million Agreement with Elan. You Betcha!!!
Bullboard Posts